Lineage Cell Therapeutics Reports Successful Preclinical Results for Cell-Based Therapy for Hearing Loss
Lineage Cell Therapeutics announced promising preclinical results for its auditory neuronal cell transplant designed to treat hearing loss.
Lineage Cell Therapeutics announced promising preclinical results for its auditory neuronal cell transplant designed to treat hearing loss.
Sensorion was recommended to continue the study of a drug candidate for the prevention of Cisplatin-Induced Ototoxicity (CIO).
Signia’s RealTime Conversation Enhancement technology, which uses multi-stream architecture, helps analyze and process group conversations.
While it’s not surprising to spot teens wearing headphones and earbuds, it’s also becoming a widespread trend among younger children, a national poll suggests.
Read MoreHearCog is a two-year randomized control trial of hearing loss and dementia being conducted by Ear Science Institute Australia.
Read MoreSound Pharmaceuticals will present the Phase 2b STOP Ototoxicity data at the Association for Research in Otolaryngology Midwinter Meeting.
Read MoreHearing care professional careers continued to maintain top spots on the U.S. News & World Report’s 100 Best Jobs for 2024 list.
Read MoreFor sudden hearing loss, high-dose therapy with common medications is associated with a higher risk of side effects, researchers say.
Read MoreComputational models mimicking the human auditory system may aid the design of hearing aids, cochlear implants, and brain-machine interfaces.
Read MoreScientists can now pinpoint where someone’s eyes are looking just by listening to their ears.
Read MoreResearchers built a system of sensors that can absorb sound waves and collect their energy to make public environments safer for hearing.
Read MoreA team of scientists will expand work to make chemistry more accessible for students who rely on American Sign Language interpreters in class.
Read MoreAsian, Hispanic, and Black children are much less likely to see ENT doctors, or otolaryngologists, and receive ear tubes for ear infections.
Read MoreAcousia Therapeutics received approval for its Phase 2 clinical trial of the otoprotectant ACOU085 for cisplatin-induced hearing loss.
Read MoreNew research indicates that social struggles experienced by the deaf are due to non-supportive environments.Â
Read MoreUSC Stem Cell scientists explain why sensory hearing cells of the inner ear don’t regenerate after damage and how we could change that.
Read MoreUniversity of Adelaide researchers have started work on developing a new vaccine that could help ward off painful ear infections in children.
Read MoreThe grant from the NIH will support a multidisciplinary translational research program on human genetic hearing loss.
Read More